Endometriosis and ovarian cancer
letter
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the epidemiological association between endometriosis and the risk of developing ovarian cancer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (4)
- The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear 2020
- Endometriosis after menopause: physiopathology and management of an uncommon condition 2017
- A research on the protein expression of p53, p16, and MDM2 in endometriosis 2019
- Macrophages in endometriosis 2021
References (5)
- Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. via openalex
- W2125681453 via openalex
- W2137849078 via openalex
- W2166050085 via openalex
- W6683952698 via openalex
Cited by (4)
- Macrophages in endometriosis 2021
- The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear 2020
- A research on the protein expression of p53, p16, and MDM2 in endometriosis 2019
- Endometriosis after menopause: physiopathology and management of an uncommon condition 2017
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:16:17.081435+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK